BDX 株価推移チャート
BDX 収入
Becton Dickinson and Co
$143.92
2.28%
$3.2
終値： Jun 23, 16:00:00 GMT-4
$143.94
0.01%
$0.02
アフターマーケット：Jun 23, 19:15:54 GMT-4
戻る
Becton Dickinson and Co (BDX) 収入
最新の利益結果: Q2 '26
報告済み: 2026-05-07
歴史的収益
四半期
年次
EPS
収入
Earnings FAQ
BDXの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
Becton Dickinson and Co BDXの前四半期の収益はどうでしたか？
Becton Dickinson and Coの収益見積もりはいくらですか？
Becton Dickinson and Coの収益品質スコアはどれくらいですか？
Becton Dickinson and Coはいつ収益を報告しますか？
Becton Dickinson and Coの予想収益はいくらですか？
Becton Dickinson and Coは収益予想を上回りましたか？
主要データ
前終値
$140.71
始値
$142.55
当日レンジ
$141.25 - $145.59
52週レンジ
$127.59 - $187.35
取引高
--
平均取引高
2.9M
配当利回り
2.92%
1株当たり利益(TTM)
3.94
時価総額
$39.6B
BDXとは何ですか？
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 72,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. The company operates through five segments: BD Medical Essentials, BD Connected Care, BD BioPharma Systems, BD Interventional, and BD Life Sciences. BD Medical Essentials segment includes medication delivery solutions and specimen management. BD Connected Care segment includes medication management solutions and advanced patient monitoring. BD Interventional segment includes urology and critical care, peripheral intervention and surgery. Its Life Sciences segment includes diagnostic solutions and biosciences.
